AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012
May 31, 2012
30583_dirs_2012-05-31_8d04d6a1-f83f-4268-bd2b-f259cbdbd9a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-05-29
Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-29 | Common Stock | A | 33000 | — | Acquired | 33000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-29 | Stock Option (right to buy) | $39.06 | A | 125000 | Acquired | 2022-05-28 | Common Stock (125000) | Direct |
Footnotes
F1: Restricted stock units granted May 29, 2012. Price not applicable.
F2: Options vest 6/48ths on November 29, 2012 and 1/48th on the 29th of each month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19